Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Octreotide may be effective in preventing or controlling diarrhea in patients who
are undergoing chemoradiotherapy for anal or rectal cancer. It is not yet known whether
octreotide is effective in treating diarrhea.
PURPOSE: This randomized phase III trial is studying octreotide in preventing or reducing
diarrhea in patients who are undergoing chemoradiotherapy for anal or rectal cancer.